Nevertheless, it remains uncertain whether these patients have an insufficient adaptive immune response or, more likely, alterations within HNSCC with HPV integration (such as TRAF3 and PIK3CA mutations) facilitate the evasion of tumour cells from the immune system. The gene discussed is TRAF3; the disease is head and neck squamous cell carcinoma.